Data for ST003501   

(Analysis AN005746): Average values per metabolite and experimental factor (Units:log2(area))

Metabolite structureAll dataF1F2F3F4F5F6
1-O-Palmitoyl-Cer(d18:1/18:0)
- - - - - -
24-Hydroxycholesterol
- - - - - -
24-Hydroxycholesterol(d7)
- - - - - -
3-O-SulfoLacCer(d18:1/18:0)
- - - - - -
4-beta-Hydroxycholesterol
- - - - - -
7-keto-Cholesterol
- - - - - -
CE(16:1)
- - - - - -
CE(18:1)
12.64 14.09 13.51 12.99 13.50 13.83
CE(18:1(d7))
16.03 16.81 16.41 16.06 16.57 16.94
CE(18:2)
- - - - - -
CE(20:4)
- - - - - -
CE(20:5)
- - - - - -
CE(22:6)
- - - - - -
CE HETE
- - - - - -
CE HODE
- - - - - -
CE HpODE
- - - - - -
CE oxoHETE
- - - - - -
CE oxoODE
- - - - - -
Cer(d18:0/16:0)
- - - - - -
Cer(d18:0/18:0)
- - - - - -
Cer(d18:0/24:0)
- - - - - -
Cer(d18:0/24:1)
- - - - - -
Cer(d18:1/16:0)
17.02 15.52 16.49 16.77 15.61 16.02
Cer(d18:1/16:0(d7))
20.67 20.78 20.78 20.77 20.76 20.80
Cer(d18:1/18:0)
16.75 17.44 16.69 16.71 15.17 15.78
Cer(d18:1/24:0)
16.38 15.05 16.22 16.57 14.87 16.51
Cer(d18:1/24:1)
18.07 16.40 17.64 17.94 16.27 17.51
Cholesterol
18.13 18.02 17.95 18.46 18.35 18.21
Cholesterol(d7)
22.90 22.99 23.00 22.96 23.01 23.00
Cholesteryl hexoside
- - - - - -
Coenzyme Q10
12.61 10.96 12.68 13.24 10.66 13.50
DG(15:0/18:1(d7))
21.07 21.34 21.20 21.34 21.29 21.38
DG(16:0_18:1)
16.11 14.61 15.66 15.91 15.31 15.88
DG(16:0_20:4)
17.14 14.84 16.38 16.25 15.20 15.94
DG(18:0_18:1)
13.76 12.79 13.50 14.24 13.35 13.95
DG(18:0_20:4)
16.18 15.69 16.48 16.35 16.06 16.58
DG(18:0_22:6)
13.89 12.46 14.55 13.78 13.57 12.61
DG(18:1/18:1)
15.98 15.11 15.55 15.95 15.79 16.11
DG(18:1_20:4)
16.19 14.15 15.47 15.20 14.12 15.08
GB3(d18:1/16:0)
- - - - - -
GB3(d18:1/18:0)
- - - - - -
GB3(d18:1/18:0(d3))
20.80 20.96 20.92 20.90 20.86 20.91
GB3(d18:1/24:0)
- - - - - -
GB3(d18:1/24:1)
- - - - - -
GlcCer(d18:1/16:0(d3))
20.05 20.09 20.11 20.14 20.12 20.17
GlcCer(d18:1(d5)/18:0)
23.13 23.28 23.23 23.22 23.23 23.27
Glucosylsphingosine(d5)
16.84 16.91 16.88 16.77 16.83 16.88
HexCer(d18:1/12:0)
- - - - - -
HexCer(d18:1/16:0)
15.23 14.31 14.91 14.64 14.69 14.34
HexCer(d18:1/18:0)
15.16 15.14 15.17 16.56 14.91 14.76
HexCer(d18:1/22:0)
16.29 15.52 16.32 17.54 15.88 16.47
HexCer(d18:1/24:0)
15.58 15.10 15.54 17.84 15.63 15.90
HexCer(d18:1/24:1)
16.65 16.91 16.62 19.61 17.60 16.59
Hexosylsphingosine
- - - - - -
LacCer(d18:1/16:0)
11.06 11.70 11.81 12.29 12.64 12.21
LacCer(d18:1/17:0)
20.46 20.56 20.53 20.56 20.54 20.54
LacCer(d18:1/18:0)
13.52 13.37 13.56 13.20 11.87 11.99
LacCer(d18:1/24:0)
- - - - - -
LacCer(d18:1/24:1)
- - - - - -
Lactosylsphingosine
- - - - - -
LPC(16:0)
21.15 20.90 21.04 21.22 21.04 21.19
LPC(16:1)
17.16 16.47 16.87 16.87 16.64 16.82
LPC(18:0)
21.20 21.24 21.02 21.30 21.15 21.21
LPC(18:1)
20.96 20.90 20.84 20.95 20.87 20.93
LPC(18:1(d7))
25.93 26.06 26.03 25.97 26.04 25.99
LPC(20:4)
18.85 18.32 18.56 18.52 18.01 18.56
LPC(22:6)
16.46 15.85 16.02 15.94 15.32 15.87
LPC(24:0)
- - - - - -
LPC(24:1)
- - - - - -
LPC(26:0)
12.77 12.68 13.00 12.61 12.93 12.86
LPC(26:1)
- - - - - -
lyso-GB3
- - - - - -
lyso-GB3-d7
18.23 18.35 18.40 18.33 18.33 18.41
lyso-GB4
- - - - - -
MG(16:0)
- - - - - -
MG(16:1)
- - - - - -
MG(18:0)
- - - - - -
MG(18:1)
12.86 11.63 11.70 11.83 11.53 11.70
MG(18:1(d7))
15.47 15.46 15.46 15.63 15.37 15.35
MG(20:4)
- - - - - -
N-Oleoylethanolamine
- - - - - -
N-Palmitoyl-O-phosphocholineserine
- - - - - -
Palmitoylethanolamine
- - - - - -
PC(15:0/18:1(d7))
27.35 27.41 27.38 27.38 27.40 27.39
PC(16:0/5:0(CHO))
13.40 12.73 13.51 13.58 12.58 14.81
PC(16:0/9:0(CHO))
13.83 14.48 14.55 14.65 13.91 15.27
PC(16:0/9:0(COOH))
14.76 14.85 15.37 15.16 14.76 15.09
PC(18:0/20:4(OH[S]))
- - - - - -
PC(18:0/20:4(OOH[S]))
- - - - - -
PC(34:1)
25.07 23.85 24.77 24.69 23.71 24.55
PC(36:1)
21.13 21.24 21.27 21.99 21.32 21.55
PC(36:2)
22.59 21.02 21.99 22.01 21.11 21.67
PC(36:4)
26.51 24.94 26.27 25.99 24.66 26.17
PC(38:4)
22.88 21.82 23.10 22.72 21.62 23.27
PC(38:6)
21.65 20.58 21.39 21.20 20.07 21.20
PC(40:5)
17.56 16.81 17.70 17.51 16.73 17.76
PC(40:6)
19.80 19.62 20.09 19.88 19.01 20.21
PC(O-16:0/0:0)
17.21 17.14 17.12 17.18 17.04 17.04
PC(O-16:0/2:0)
- - - - - -
PC(O-18:0/2:0)
14.53 14.35 14.11 14.81 14.45 14.46
PE(15:0/18:1(d7))
22.48 22.62 22.58 22.57 22.58 22.59
PE(18:0/20:4(OH[S]))
- - - - - -
PE(18:0/20:4(OOH[S]))
- - - - - -
PE(34:1)
19.49 17.97 18.83 19.08 17.90 17.84
PE(36:1)
18.12 17.97 18.17 19.37 18.49 18.28
PE(36:2)
19.01 18.03 18.23 19.12 18.57 17.44
PE(36:4)
20.36 18.18 19.73 19.42 17.91 19.01
PE(38:4)
20.88 20.04 20.96 20.79 19.97 20.85
PE(38:5)
19.34 17.67 18.84 18.84 17.92 18.56
PE(38:6)
21.33 19.93 20.76 20.69 19.52 20.04
PE(40:4)
17.82 17.63 17.89 18.17 17.74 17.60
PE(40:5)
- - - - - -
PE(40:6)
20.28 19.98 20.57 20.45 19.61 20.66
PE(40:7)
20.06 18.51 19.58 19.49 18.32 18.93
Sitosteryl hexoside
12.48 12.77 12.85 13.86 12.53 12.13
SM(d18:1/16:0)
21.99 21.91 21.75 22.10 22.12 21.69
SM(d18:1/18:0)
19.39 19.19 19.56 20.00 19.12 19.70
SM(d18:1/24:0)
17.92 17.42 18.04 18.50 17.49 18.58
SM(d18:1/24:1)
20.36 19.84 20.40 20.72 20.17 20.61
SM(d18:1(d9)/18:1)
26.11 26.17 26.18 26.13 26.17 26.19
Sphinganine
- - - - - -
Sphinganine 1-phosphate
- - - - - -
Sphingosine
- - - - - -
Sphingosine 1-phosphate
- - - - - -
Sphingosine 1-phosphate-d7
- - - - - -
Sphingosine 1-phosphocholine
- - - - - -
Sphingosine(d17:1)
17.92 17.96 17.99 17.98 17.86 18.01
TG(15:0/18:1(d7)/15:0)
20.48 21.66 21.05 20.78 21.29 21.75
TG(18:0_36:2)
13.66 13.44 14.02 13.64 13.52 13.74
TG(18:1_34:2)
14.41 14.44 14.39 14.61 14.51 14.74
TG(18:1_34:3)
- - - - - -
TG(20:4_32:1)
- - - - - -
TG(20:4_34:2)
- - - - - -
TG(20:4_34:3)
- - - - - -
TG(20:4_36:0)
- - - - - -
TG(20:4_36:2)
- - - - - -
TG(20:4_36:3)
- - - - - -
TG(22:6_36:2)
- - - - - -
TG(22:6_38:1)
- - - - - -
TG(22:6_38:2)
- - - - - -

Factors:

F1genotype:APP | condition:high | group:high_disease | Sample source:microglia
F2genotype:APP | condition:low | group:low_disease | Sample source:microglia
F3genotype:APP | condition:mid | group:mid_disease | Sample source:microglia
F4genotype:NA | condition:NA | group:NA | Sample source:microglia
F5genotype:WT | condition:low | group:low_healthy | Sample source:microglia
F6genotype:WT | condition:mid | group:mid_healthy | Sample source:microglia
  logo